Cancer Options Blog

This blog is a way of sharing, supporting and educating anyone dealing with a cancer-related illness about the options and treatments they have at their disposal.

You're browsing: Home » Blog » Archive by category 'Cancer Options'


You are currently browsing the archives for the
Cancer Options category.

Articles and advice that talk about different treatment options available for those with cancer.

New Web Site Helps Doctors And Prostate Cancer Patients Make Better Treatment Choices

ScienceDaily (Sep. 23, 2008) — Doctors have created a free online computer tool, the CaP Calculator, that provides cancer specialists access to the latest prostate cancer research and helps them better individiualize each patient’s treatment options, according to a study presented in a scientific session on September, 23, 2008, at the American Society for Therapeutic […]

 

September is Prostate Cancer Awareness Month

Doctors will diagnose more than 186,000 US men with prostate cancer this year.
And, each patient will have to weigh their treatment options and learn more about the diagnosis.
That’s why September has been declared National Prostate Cancer Awareness Month - spot lighting this highly treatable disease.
Prostate cancer is the most common non-skin cancer in America, affecting […]

 

MRI combo spots prostate cancer treatment failure

Two imaging modalities used in combination — dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI)-MRI — can accurately spot residual or recurrent prostate cancer in patients treated with a fairly new treatment called high-intensity focused ultrasonic ablation, a new study shows.Together these two imaging modalities are better than either modality alone, researchers say.
High-intensity […]

 

Prostate Cancer Hormone Therapy Treatment Questioned

Hormone therapy, an aggressive treatment for prostate cancer, may be overused, a new study suggests.Treatment used to reduce the size of the prostate has been shown to improve survival in advanced cancers, but doctors have increasingly been giving hormone therapy in less-severe cases.
The study, published in this week’s New England Journal of Medicine, charted the […]

 

Chemo Break Benefits Some Men With Prostate Cancer

FRIDAY, Feb. 29 (HealthDay News) — Some men with advanced prostate cancer can safely take a break from chemotherapy, says a study by researchers at the Oregon Health & Science University Cancer Institute.The study included 250 men with metastatic, androgen-independent prostate cancer — disease that spreads from the prostate and isn’t affected by the male […]

 

Unproven cancer therapy lures U.S. men to Mexico

Article from The New York Times
By Stephanie Saul
PUERTO VALLARTA, Mexico - Some weekends, more than a dozen American men wait at beachfront hotels, eager for their turns in the treatment room at a small private hospital here.
They are medical tourists with prostate cancer. And they are queued up for the latest therapy - one advertised […]

 

ASTRO’s 49th annual meeting of radiation oncology

ProxcelanTM (Cesium-131) is the newest advancement in permanent brachytherapy seed implants for prostate cancerLOS ANGELES, CA - Several newly released scientific findings focusing on various aspects of ProxcelanTM (Cesium-131) seeds’ effectiveness in the treatment of prostate cancer–supporting and broadening the growing body of evidence on the newest medical isotope being used in permanent seed therapy.
The […]

 

Proxcelan™ with Cesium-131 advantages

Proxcelan™ (Cesium-131) brachytherapy seeds offer patients unique advantages over other medical isotopes. Increasingly, prostate cancer patients and their doctors who decide on seed brachytherapy choose Cesium-131 treatment because of its significant advantages over Palladium-103 and Iodine-125, two other isotopes currently in use. These advantages include Higher Energy, Shorter Half-Life, and Higher Biologically Effective Dose.
For […]

 

Newest isotope used in brachytherapy for prostate cancer

FOR IMMEDIATE RELEASE: July 20, 2007
Scientific abstracts on the newest isotope used in brachytherapy for prostate cancer–IsoRay Medical’s Proxcelan™ with Cesium-131–presented at the American Association of Physicists in Medicine (AAPM) annual conference, July 22-26
RICHLAND, Washington - Noted medical researchers from around the country will gather at the 26th annual American Association of […]

 

  • Categories

  • Subscribe

    All posts by all authors Google Reader or Homepage Subscribe Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online Add to My AOL Subscribe in Rojo Add to Technorati Favorites!
    Business Blogs - BlogCatalog Blog Directory

    Enter your email address:

    Comments (RSS)

  • Random Posts & Pages

    Statins Lower Blood Marker for Prostate Cancer

  • But it's not clear if the cholesterol-lowering drugs protect against the disease Posted October 30, 2008 By Ed Edelson HealthDay Reporter  THURSDAY, Oct. 30 (HealthDay News) -- A new study shows that men who take cholesterol-lowering drugs called statins have lower blood levels of prostate-specific antigen (PSA), a biomarker for prostate cancer risk. That drop

    • ASTRO: Brachytherapy Called Prostate Cancer Option for Younger Men

  • By Michael Smith, Senior Staff Writer, MedPage Today Published: October 31, 2007 Reviewed by Zalman S. Agus, MD; Emeritus Professor at the University of Pennsylvania School of Medicine. LOS ANGELES, Oct. 31 -- Younger men with prostate cancer benefit just as much from brachytherapy as older men, a researcher said here.Younger age is often thought

    • September is Prostate Cancer Awareness Month

  • Doctors will diagnose more than 186,000 US men with prostate cancer this year. And, each patient will have to weigh their treatment options and learn more about the diagnosis. That's why September has been declared National Prostate Cancer Awareness Month - spot lighting this highly treatable disease. Prostate cancer is the most common

    • Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes

  • Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes ScienceDaily (Jan. 2, 2009) — In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this

    • New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading

  • New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading ScienceDaily (Feb. 12, 2009) — Howard Hughes Medical Institute researchers have identified a new biological marker present in the urine of patients with prostate cancer that indicates whether the cancer is progressing and spreading. In experiments reported in the journal Nature, the

    • Man-A-Grams Urged For Prostate Cancer

  • Man-A-Grams Urged For Prostate Cancer By Will DunhamWASHINGTON JAN 14, 2009 (Reuters) - Prostate cancer experts urged the U.S. Congress and the incoming Obama administration on Wednesday to make a major research commitment to find better detection methods, including what they call a "man-o-gram." Their idea involves a sophisticated ultrasound, magnetic resonance

    • Research shows that soy decreases the risk of breast and prostate cancers

  • A new soy protein-packed, low-fat, high-fiber cereal meets the requirements for three different FDA health claims and leaves you feeling full so you won't be tempted to eat again until lunch.University of Illinois scientist Soo-Yeun Lee has a recipe for just such a cereal, one that's passed the taste test

    • MR Spectroscopy May Help Diagnose, Determine Aggressiveness Of Prostate Cancer

  • Magnetic resonance (MR) spectroscopy - which analyzes the biochemistry rather than the structure of tissues - may someday be able both to pinpoint the precise location of prostate cancer and to determine the tumor's aggressiveness, information that could help guide treatment planning. In the January 27 online issue of Science

    • Stereotactic Radiotherapy ''Promising'' For Early Prostate Cancer

  • Stereotactic Radiotherapy ''Promising'' For Early Prostate Cancer Last Updated: 2009-03-23 8:00:11 -0400 (Reuters Health)NEW YORK (Reuters Health) - The results of a small phase II trial suggest that stereotactic body radiotherapy (SBRT), which involves a higher dose but shorter course than standard external beam radiotherapy, is a safe and effective treatment for

    • Contact

  • Lori Woods 350 Hills Street, Suite 106 Richland, WA 99354 Phone (509) 375-1202 Email: lwoods@isoray.com


  •  

    July 2010
    M T W T F S S
    « Jan    
     1234
    567891011
    12131415161718
    19202122232425
    262728293031  
images